Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Recro Pharma Inc.

    NASDAQ: REPH · Real-Time Price · USD
    2.09
    -0.01 (-0.48%)
    At close: Mar 22, 2022, 5:00 AM

    Recro Pharma Cash Flow Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -13.27M -19.88M -11.37M
    Depreciation & Amortization
    		 8.91M 8.32M 7.57M
    Stock-Based Compensation
    		 n/a n/a n/a
    Other Working Capital
    		 n/a 6.23M 1.9M
    Other Non-Cash Items
    		 n/a 7.71M 2.46M
    Deferred Income Tax
    		 89K 1.01M n/a
    Change in Working Capital
    		 n/a -6.23M 5.68M
    Operating Cash Flow
    		 -1M -3.64M 10.86M
    Capital Expenditures
    		 -8.24M -8.35M -5.29M
    Cash Acquisitions
    		 n/a n/a -24M
    Purchase of Investments
    		 n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a
    Investing Cash Flow
    		 -8.24M -8.35M -29.29M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a -751K
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 2.34M 1.77M 19.89M
    Financial Cash Flow
    		 2.34M 1.77M 19.89M
    Net Cash Flow
    		 -6.9M -10.22M 1.46M
    Free Cash Flow
    		 -9.24M -11.99M 5.57M

    Add to Watchlist